Target intelligence / Profile preview

B9 domain-containing protein 2 (B9D2)

Target
B9D2
Molecular classification
Other (Ciliary structural protein; Transition zone complex component)
01

Overview

B9 domain-containing protein 2 (B9D2) is a highly conserved ciliary protein found exclusively in ciliated organisms[1][4][5]. It localizes primarily to the transition zone at the base of cilia, where it forms a critical heterotrimeric complex with MKS1 and B9D1[1][3][4][5]. This complex serves as a selective diffusion barrier for ciliary membrane proteins, facilitating compartmentalization of signaling pathways such as Hedgehog signaling and playing a decisive role in ciliogenesis and ciliary membrane organization[1][3][4][5]. Loss of B9D2 disrupts the formation and maintenance of both motile and primary cilia, resulting in severe multi-organ developmental defects associated with ciliopathies including Meckel-Gruber syndrome and Joubert syndrome[1][2]. Beyond its ciliary functions, B9D2 is crucial for the maturation and maintenance of epithelial tight junctions and cell polarity, impacting tissue architecture during development (notably in the liver)[2]. There are no known therapeutic drugs or direct modulators targeting B9D2.

Other names
MKSR2MKS10JBTS34ICIS-1MKS1-related protein 2involved in cilia stability-1B9 protein domain 2B9D2
02

Biological functions

Ciliogenesis (formation of cilia)Formation and maintenance of ciliary transition zoneEstablishment and maintenance of tight junctions and epithelial polarityMembrane protein diffusion barrier at cilia
03

Disease associations

Ciliopathies, including Meckel-Gruber syndrome and Joubert syndromeDefects in biliary tubulogenesis (liver developmental disorder)
04

Safety considerations

Disruption of B9D2 function leads to severe developmental defects and multi-organ disorder due to defective ciliary structure and signalingLoss causes loss of epithelial tight junction maturation and polarity (implicated in liver cysts, developmental disease)

Beyond the preview

Go deeper on B9 domain-containing protein 2 (B9D2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B9 domain-containing protein 2 (B9D2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call